结果页面 2，行业：药品制造商 – 仿制药，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
所有国家
所有交流
- {{item.name}}
- 所有交流
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (4)
- IOB (17)
- Istanbul (1)
- Jakarta (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (9)
- OTC Markets OTCPK (30)
- OTC Markets OTCQX (3)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (11)
- Shenzhen (11)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
所有版块
- {{item.name}}
- 所有版块
- 医疗保健 (279)
药品制造商 – 仿制药 (279)
- {{item.name}}
- 所有行业
- 农业投入 (323)
- 建筑材料 (471)
- 化学品 (605)
- 特种化学品 (1353)
- 木材和木材生产 (160)
- 纸和纸制品 (269)
- 铝 (141)
- 铜 (216)
- 其他工业金属和采矿 (2765)
- 金 (1700)
- 银 (84)
- 其他贵金属和采矿 (660)
- 炼焦煤 (71)
- 钢 (744)
- 汽车和卡车经销商 (212)
- 汽车制造商 (388)
- 汽车零部件 (1166)
- 休闲车 (85)
- 家具、固定装置和器具 (507)
- 住宅建筑 (214)
- 纺织品制造 (520)
- 服装制造 (444)
- 鞋类和配件 (208)
- 包装和容器 (481)
- 个人服务 (140)
- 餐厅 (539)
- 服装零售 (289)
- 百货商店 (276)
- 家居装饰零售 (106)
- 奢侈品 (260)
- 互联网零售 (408)
- 专业零售 (547)
- 博彩 (205)
- 休闲 (411)
- 住宿 (321)
- 度假村和赌场 (188)
- 旅行服务 (192)
- 资产管理 (1966)
- 银行 – 多元化 (308)
- 银行 – 区域 (2297)
- 抵押贷款融资 (171)
- 资本市场 (888)
- 金融数据和股票交易所 (151)
- 保险 – 人寿 (260)
- 保险 – 财产和意外伤害 (270)
- 保险 – 再保险 (74)
- 保险 – 专业 (72)
- 保险经纪人 (67)
- 保险 – 多元化 (306)
- 空壳公司 (1820)
- 金融集团 (100)
- 信贷服务 (660)
- 房地产 – 开发 (966)
- 房地产服务 (1145)
- 房地产 – 多元化 (316)
- 房地产投资信托 – 医疗保健设施 (64)
- 房地产投资信托 – 酒店和汽车旅馆 (86)
- 房地产投资信托 – 工业 (141)
- 房地产投资信托 – 办公室 (169)
- 房地产投资信托 – 住宅 (108)
- 房地产投资信托 – 零售 (230)
- 房地产投资信托 – 抵押贷款 (130)
- 房地产投资信托 – 专业 (83)
- 房地产投资信托 – 多元化 (332)
- 酒水 – 啤酒制造商 (162)
- 酒水 – 酒庄和酿酒厂 (242)
- 酒水 – 非酒精类 (217)
- 糖果商 (170)
- 农产品 (610)
- 家用和个人用品 (523)
- 包装食品 (1270)
- 教育和培训服务 (305)
- 折扣店 (97)
- 食品配送 (210)
- 食品杂货店 (233)
- 烟草 (105)
- 生物技术 (2611)
- 药品制造商 – 仿制药 (279)
- 药品制造商 – 特药和仿制药 (1705)
- 医疗保健计划 (57)
- 医疗保健设施 (553)
- 医药零售商 (155)
- 健康信息服务 (419)
- 医疗器械 (913)
- 医疗仪器和用品 (501)
- 诊断和研究 (427)
- 医药分销 (138)
- 公用事业 – 独立发电公司 (170)
- 公用事业 – 可再生能源 (561)
- 公用事业 – 管制水 (173)
- 公用事业 – 管制电 (468)
- 公用事业 – 管制天然气 (205)
- 公用事业 – 多元化 (214)
- 电信服务 (910)
- 广告代理机构 (508)
- 出版 (259)
- 广播 (213)
- 娱乐 (679)
- 互联网内容和信息 (530)
- 电子游戏和多媒体 (484)
- 石油和天然气钻探 (80)
- 石油和天然气勘探与生产 (1185)
- 石油和天然气一体化 (246)
- 石油和天然气中游 (230)
- 石油和天然气精炼与营销 (278)
- 石油和天然气设备与服务 (480)
- 热能煤 (229)
- 铀 (140)
- 航空航天与国防 (560)
- 专业商业服务 (640)
- 咨询服务 (195)
- 出租和租赁服务 (219)
- 安全与保护服务 (267)
- 人事与就业服务 (252)
- 综合性企业 (723)
- 工程与建筑 (1492)
- 基础设施运营 (156)
- 建筑产品和设备 (513)
- 农用和重型工程机械 (376)
- 工业分销 (235)
- 商业设备和用品 (142)
- 特种工业机械 (1720)
- 金属加工 (393)
- 污染与处理控制 (265)
- 工具和配件 (240)
- 电气设备与零件 (897)
- 机场和航空服务 (135)
- 航空公司 (229)
- 铁路 (260)
- 海运 (505)
- 货车运输 (99)
- 综合货运与物流 (388)
- 废物管理 (354)
- 信息技术服务 (1178)
- 软件 – 应用程序 (2113)
- 软件 – 基础设施 (955)
- 通信设备 (731)
- 计算机硬件 (434)
- 消费电子产品 (282)
- 电子元器件 (971)
- 电子和计算机分销 (239)
- 科学技术仪器 (347)
- 半导体设备与材料 (350)
- 半导体 (611)
- 太阳能 (222)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Eli Lilly and Company LLY.SW | $620 705.43 USD |
-22.98
|
$556.75B 633.47B USD | $42 47.79 USD | $780 887.47 USD | $780 887.47 USD | $556.75B 633.47B USD | 61.63 | $10.06 11.45 USD | |
| Johnson & Johnson JNJ.BA | $13,650 16.13 USD |
-0.36
|
$390.09T 461.1B USD | $9.26K 10.95 USD | $13,550 16.02 USD | $14,000 16.55 USD | $390.09T 461.1B USD | 10.92 | $1.25K 1.48 USD | |
| Johnson & Johnson JNJ.MX | $3,149.99 186.52 USD |
+1.21
|
$7.59T 449.48B USD | $1.46K 86.45 USD | $3,117.42 184.59 USD | $3,187.18 188.72 USD | $7.59T 449.48B USD | 26.35 | $119.51 7.08 USD | |
| Johnson & Johnson JNJB34.SA | $59.15 11.99 USD |
+1.04
|
$2.14T 434.49B USD | $4.29K 869.72 USD | $59.15 11.99 USD | $60.8 12.32 USD | $2.14T 434.49B USD | 26.28 | $2.25 0.46 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV.BA | $23,875 28.22 USD |
-6.19
|
$333.93T 394.71B USD | $906 1.07 USD | $23,775 28.1 USD | $25,625 30.29 USD | $333.93T 394.71B USD | 9.26 | $2.58K 3.05 USD | |
| AbbVie Inc. ABBV.MX | $3,670 217.31 USD |
-6.19
|
$6.49T 384.42B USD | $67 3.97 USD | $3,670 217.31 USD | $3,670 217.31 USD | $6.49T 384.42B USD | 74.45 | $49.29 2.92 USD | |
| AbbVie Inc. ABBV34.SA | $64.43 13.06 USD |
-5.22
|
$1.83T 370.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.83T 370.54B USD | 74.05 | $0.87 0.18 USD | |
| Johnson & Johnson JNJ.VI | $138.82 151.75 USD |
+2.34
|
$338.24B 369.75B USD | $785 858.11 USD | $138.82 151.75 USD | $141.94 155.16 USD | $338.24B 369.75B USD | 26.24 | $5.29 5.78 USD | |
| Johnson & Johnson JNJ.F | $135.5 148.12 USD |
-1.71
|
$326.53B 356.95B USD | $2.32K 2.53K USD | $135.5 148.12 USD | $142.04 155.27 USD | $326.53B 356.95B USD | 25.71 | $5.27 5.76 USD | |
| AbbVie Inc. ABBV.VI | $171.8 187.8 USD |
+3.12
|
$309.86B 338.72B USD | $0 0 USD | $171.2 187.14 USD | $171.8 187.8 USD | $309.86B 338.72B USD | 78.80 | $2.18 2.38 USD | |
| AbbVie Inc. 4AB.F | $172.2 188.24 USD |
+0.94
|
$304.62B 332.99B USD | $837 914.95 USD | $170.6 186.49 USD | $174.2 190.42 USD | $304.62B 332.99B USD | 78.99 | $2.18 2.38 USD | |
| AbbVie Inc. 4AB.DE | $168.8 184.52 USD |
+0.96
|
$303.35B 331.6B USD | $1.59K 1.73K USD | $167.2 182.77 USD | $173.6 189.77 USD | $303.35B 331.6B USD | 77.78 | $2.17 2.37 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Roche Holding AG ROGN.MX | $6,215 368 USD |
-1.04
|
$4.74T 280.5B USD | $66 3.91 USD | $6,215 368 USD | $6,215 368 USD | $4.74T 280.5B USD | 24.86 | $249.95 14.8 USD | |
| Novartis AG NVSN.MX | $2,235 132.34 USD |
0
|
$4.41T 261.38B USD | $0 0 USD | $2,235 132.34 USD | $2,235 132.34 USD | $4.41T 261.38B USD | 18.44 | $121.14 7.17 USD | |
| Novartis AG NVS.BA | $35,325 41.76 USD |
+0.5
|
$218.97T 258.83B USD | $19 0.02 USD | $35,325 41.76 USD | $35,675 42.17 USD | $218.97T 258.83B USD | 2.78 | $12.66K 14.97 USD | |
| AstraZeneca PLC AZN.BA | $44,500 52.6 USD |
-0.73
|
$215.48T 254.7B USD | $1.21K 1.43 USD | $44,500 52.6 USD | $45,700 54.02 USD | $215.48T 254.7B USD | 9.16 | $4.85K 5.74 USD | |
| Merck & Co., Inc. MRK.BA | $21,350 25.24 USD |
-3.72
|
$212.96T 251.73B USD | $7.28K 8.6 USD | $21,325 25.21 USD | $22,350 26.42 USD | $212.96T 251.73B USD | 0.29 | $72.7K 85.93 USD | |
| AstraZeneca PLC AZNN.MX | $1,360 80.53 USD |
-8.72
|
$4.22T 249.67B USD | $335 19.84 USD | $1,360 80.53 USD | $1,360 80.53 USD | $4.22T 249.67B USD | 29.25 | $46.49 2.75 USD | |
| Novartis AG N1VS34.SA | $62.09 12.58 USD |
-1.02
|
$1.23T 248.56B USD | $2 0.41 USD | $62.09 12.58 USD | $62.1 12.59 USD | $1.23T 248.56B USD | 18.10 | $3.43 0.7 USD | |
| Merck & Co., Inc. MRK.MX | $1,632.92 96.69 USD |
-2.74
|
$4.12T 244.24B USD | $65 3.85 USD | $1,632.92 96.69 USD | $1,690 100.07 USD | $4.12T 244.24B USD | 11.73 | $139.19 8.24 USD | |
| Merck & Co., Inc. MRK.SN | $96.42 — |
-25.14
|
$243.56B — | $0 — | $96.42 — | $96.42 — | $243.56B — | 14.30 | $6.74 — | |
| AstraZeneca PLC A1ZN34.SA | $64.38 13.05 USD |
+0.16
|
$1.2T 242.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.2T 242.74B USD | 29.39 | $2.19 0.44 USD | |
| Roche Holding AG RHO6.F | $33.4 36.51 USD |
+3.05
|
$217.5B 237.75B USD | $150 163.97 USD | $33.23 36.32 USD | $33.4 36.51 USD | $217.5B 237.75B USD | 24.20 | $1.38 1.51 USD | |
| Merck & Co., Inc. MRCK34.SA | $57.97 11.75 USD |
-2.56
|
$1.17T 237.44B USD | $13.95K 2.83K USD | $57.97 11.75 USD | $61.21 12.41 USD | $1.17T 237.44B USD | 11.75 | $4.93 1 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Roche Holding AG RHHVF | $287 — |
-0.59
|
$231.83B — | $20 — | $287 — | $287.16 — | $231.83B — | 23.97 | $11.97 — | |
| Roche Holding AG RHHBF | $310.95 — |
0
|
$231.79B — | $50 — | $325 — | $330.5 — | $231.79B — | 25.97 | $11.97 — | |
| AstraZeneca PLC AZNCF | $131.6 — |
+3.05
|
$222.11B — | $100 — | $131.6 — | $131.6 — | $222.11B — | 29.24 | $4.5 — | |
| AstraZeneca PLC ZEG.F | $122.4 133.8 USD |
+1.12
|
$200.77B 219.47B USD | $3.51K 3.84K USD | $119.2 130.3 USD | $124.75 136.37 USD | $200.77B 219.47B USD | 29.92 | $4.09 4.47 USD | |
| AstraZeneca PLC ZEGA.F | $60.5 66.13 USD |
-0.82
|
$196.93B 215.27B USD | $65 71.05 USD | $60.5 66.13 USD | $60.5 66.13 USD | $196.93B 215.27B USD | 29.51 | $2.05 2.24 USD | |
| Novartis AG NOTA.F | $96.4 105.38 USD |
+1.47
|
$190.4B 208.13B USD | $171 186.93 USD | $92.8 101.44 USD | $96.4 105.38 USD | $190.4B 208.13B USD | 18.01 | $5.35 5.85 USD | |
| Merck & Co., Inc. MRK.VI | $73.9 80.78 USD |
+0.41
|
$187.48B 204.94B USD | $970 1.06K USD | $73.9 80.78 USD | $76.8 83.95 USD | $187.48B 204.94B USD | 12.01 | $6.15 6.72 USD | |
| Amgen Inc. AMGN.MX | $6,430 380.73 USD |
0
|
$3.45T 204.53B USD | $0 0 USD | $6,430 380.73 USD | $6,430 380.73 USD | $3.45T 204.53B USD | 41.15 | $156.25 9.25 USD | |
| Merck & Co., Inc. 6MK.F | $72 78.71 USD |
-3.23
|
$181.87B 198.81B USD | $4.58K 5.01K USD | $72 78.71 USD | $77.2 84.39 USD | $181.87B 198.81B USD | 11.72 | $6.14 6.71 USD | |
| Amgen Inc. AMGN.BA | $12,750 15.07 USD |
-2.86
|
$163.07T 192.75B USD | $276 0.33 USD | $12,700 15.01 USD | $13,325 15.75 USD | $163.07T 192.75B USD | 0.31 | $40.77K 48.19 USD | |
| Amgen Inc. AMGN34.SA | $60.11 12.18 USD |
-1.48
|
$904.16B 183.26B USD | $0 0 USD | $0 0 USD | $0 0 USD | $904.16B 183.26B USD | 38.04 | $1.58 0.32 USD | |
| Gilead Sciences, Inc. GILD.BA | $35,075 41.46 USD |
-2.3
|
$138.63T 163.86B USD | $802 0.95 USD | $35,000 41.37 USD | $36,700 43.38 USD | $138.63T 163.86B USD | 85.70 | $409.26 0.48 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,191.09 129.74 USD |
0
|
$2.73T 161.74B USD | $92 5.45 USD | $2,191.09 129.74 USD | $2,191.09 129.74 USD | $2.73T 161.74B USD | 277.70 | $7.89 0.47 USD | |
| Gilead Sciences, Inc. GILD34.SA | $319 64.66 USD |
+2.3
|
$795.35B 161.2B USD | $0 0 USD | $0 0 USD | $0 0 USD | $795.35B 161.2B USD | 284.82 | $1.12 0.23 USD | |
| Pfizer Inc. PFE.BA | $7,470 8.83 USD |
-2.86
|
$134.48T 158.96B USD | $26.68K 31.54 USD | $7,360 8.7 USD | $7,760 9.17 USD | $134.48T 158.96B USD | 2.45 | $3.04K 3.6 USD | |
| Amgen Inc. AMG.F | $260.95 285.25 USD |
+2.33
|
$145.01B 158.51B USD | $113 123.52 USD | $260.95 285.25 USD | $268 292.96 USD | $145.01B 158.51B USD | 37.87 | $6.89 7.53 USD | |
| Amgen Inc. AMGN.VI | $266.7 291.54 USD |
+1.72
|
$144.13B 157.56B USD | $420 459.12 USD | $262.9 287.39 USD | $268.4 293.4 USD | $144.13B 157.56B USD | 38.65 | $6.9 7.54 USD | |
| Amgen Inc. AMG.DE | $267.55 292.47 USD |
+1.59
|
$143.96B 157.37B USD | $289 315.92 USD | $261.8 286.18 USD | $270.5 295.69 USD | $143.96B 157.37B USD | 38.94 | $6.87 7.51 USD | |
| Pfizer Inc. PFE.MX | $454.71 26.92 USD |
-2.53
|
$2.58T 152.97B USD | $1.79K 105.69 USD | $449 26.59 USD | $469.27 27.79 USD | $2.58T 152.97B USD | 15.62 | $29.11 1.72 USD | |
| Pfizer Inc. PFE.SN | $26.06 — |
0
|
$147.8B — | $0 — | $26.06 — | $26.06 — | $147.8B — | 18.48 | $1.41 — | |
| Pfizer Inc. PFIZ34.SA | $32.07 6.5 USD |
-3.02
|
$727.53B 147.46B USD | $17.23K 3.49K USD | $32.07 6.5 USD | $33.76 6.84 USD | $727.53B 147.46B USD | 15.56 | $2.06 0.42 USD | |
| Gilead Sciences, Inc. GILD.SN | $95.78 — |
+6.77
|
$140.45B — | $0 — | $95.78 — | $95.78 — | $140.45B — | 252.05 | $0.38 — | |
| Bristol-Myers Squibb Company BMY.BA | $24,250 28.66 USD |
-3.39
|
$117.03T 138.33B USD | $760 0.9 USD | $23,950 28.31 USD | $25,075 29.64 USD | $117.03T 138.33B USD | 0 | -$4,756 -5.6 USD | |
| Bristol-Myers Squibb Company BMY.MX | $1,133.23 67.1 USD |
0
|
$2.32T 137.32B USD | $2 0.12 USD | $1,133.23 67.1 USD | $1,133.23 67.1 USD | $2.32T 137.32B USD | 0 | -$91.1 -5.3 USD | |
| Gilead Sciences, Inc. GIS.DE | $97.56 106.65 USD |
+1.12
|
$121.62B 132.95B USD | $2.96K 3.24K USD | $95.65 104.56 USD | $98.39 107.55 USD | $121.62B 132.95B USD | 278.74 | $0.35 0.38 USD | |
| Gilead Sciences, Inc. GILD.VI | $97.39 106.46 USD |
+1.38
|
$121.43B 132.74B USD | $874 955.4 USD | $95.87 104.8 USD | $97.62 106.71 USD | $121.43B 132.74B USD | 278.25 | $0.35 0.38 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Sanofi SNYNF | $100.55 — |
+1.57
|
$129.46B — | $200 — | $99 — | $99 — | $129.46B — | 20.90 | $4.81 — | |
| Gilead Sciences, Inc. GIS.F | $94.12 102.89 USD |
-1.47
|
$118.02B 129.01B USD | $3.05K 3.33K USD | $94.12 102.89 USD | $98.39 107.55 USD | $118.02B 129.01B USD | 276.82 | $0.34 0.37 USD | |
| Sanofi SANO.VI | $93.37 102.07 USD |
+0.09
|
$117.33B 128.26B USD | $369 403.37 USD | $91.33 99.84 USD | $93.65 102.37 USD | $117.33B 128.26B USD | 21.26 | $4.39 4.8 USD | |
| Pfizer Inc. PFE.VI | $20.38 22.28 USD |
-0.2
|
$116.63B 127.5B USD | $5.35K 5.85K USD | $20.38 22.28 USD | $21.09 23.05 USD | $116.63B 127.5B USD | 15.79 | $1.29 1.41 USD | |
| Pfizer Inc. PFEB.F | $6.45 7.05 USD |
-0.77
|
$115.96B 126.76B USD | $209 228.47 USD | $6.45 7.05 USD | $6.45 7.05 USD | $115.96B 126.76B USD | 14.65 | $0.44 0.48 USD | |
| Sanofi SNW2.F | $46.4 50.72 USD |
-1.28
|
$115.73B 126.51B USD | $100 109.31 USD | $46.2 50.5 USD | $46.6 50.94 USD | $115.73B 126.51B USD | 21.18 | $2.19 2.39 USD | |
| Sanofi SNW.F | $92 100.57 USD |
-2.13
|
$114.74B 125.42B USD | $2.49K 2.73K USD | $91.3 99.8 USD | $94 102.75 USD | $114.74B 125.42B USD | 20.95 | $4.39 4.8 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $299.01 60.6 USD |
-7.49
|
$608.41B 123.32B USD | $0 0 USD | $0 0 USD | $0 0 USD | $608.41B 123.32B USD | 0 | -$25.78 -5.2 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $50.37 55.06 USD |
+2.64
|
$104.95B 114.72B USD | $0 0 USD | $50.12 54.79 USD | $50.66 55.38 USD | $104.95B 114.72B USD | 0 | -$4.02 -4.3 USD | |
| Bristol-Myers Squibb Company BRM.DE | $49.88 54.52 USD |
+0.97
|
$103.24B 112.86B USD | $1.34K 1.47K USD | $49.88 54.52 USD | $50.78 55.51 USD | $103.24B 112.86B USD | 0 | -$4.02 -4.3 USD | |
| GSK plc GSK.BA | $11,625 13.74 USD |
-2.92
|
$94.41T 111.59B USD | $386 0.46 USD | $11,600 13.71 USD | $11,950 14.13 USD | $94.41T 111.59B USD | 26.81 | $433.5 0.51 USD | |
| Bristol-Myers Squibb Company BRM.F | $48.88 53.43 USD |
-1.93
|
$100.28B 109.62B USD | $145 158.5 USD | $48.88 53.43 USD | $50.92 55.66 USD | $100.28B 109.62B USD | 0 | -$4.02 -4.3 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $811 48.02 USD |
0
|
$1.65T 97.5B USD | $0 0 USD | $811 48.02 USD | $811 48.02 USD | $1.65T 97.5B USD | 24.44 | $33.17 1.96 USD | |
| GSK plc G1SK34.SA | $41.55 8.42 USD |
+1.24
|
$421.79B 85.49B USD | $0 0 USD | $0 0 USD | $0 0 USD | $421.79B 85.49B USD | 22.10 | $1.88 0.38 USD | |
| GSK GLAXF | $17 — |
-15.51
|
$75.34B — | $497 — | $17 — | $17 — | $75.34B — | 21.25 | $0.8 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $40.82 44.62 USD |
+4.56
|
$68.86B 75.27B USD | $30 32.79 USD | $40.07 43.8 USD | $40.82 44.62 USD | $68.86B 75.27B USD | 27.76 | $1.47 1.61 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $21.07 23.03 USD |
+4.72
|
$41.36B 45.22B USD | $200 218.63 USD | $20.5 22.41 USD | $21.07 23.03 USD | $41.36B 45.22B USD | 26.01 | $0.81 0.89 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $44.4 48.54 USD |
+1.37
|
$24.43B 26.7B USD | $420 459.12 USD | $44.4 48.54 USD | $44.4 48.54 USD | $24.43B 26.7B USD | 11.18 | $3.97 4.34 USD | |
| Biogen Inc. BIIB.MX | $2,854 168.99 USD |
0
|
$417.75B 24.74B USD | $0 0 USD | $2,854 168.99 USD | $2,854 168.99 USD | $417.75B 24.74B USD | 12.36 | $230.89 13.67 USD | |
| Bayer Aktiengesellschaft BAYER.BD | $8,420 23.29 USD |
+5.25
|
$8.35T 23.09B USD | $250 0.69 USD | $8,208 22.7 USD | $8,422 23.29 USD | $8.35T 23.09B USD | 0 | -$1,055.2 -2.9 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $20.72 22.64 USD |
+4.23
|
$20.35B 22.25B USD | $1.27K 1.39K USD | $20 21.86 USD | $20.76 22.69 USD | $20.35B 22.25B USD | 0 | -$2.6 -2.8 USD | |
| Biogen Inc. BIIB.BA | $12,025 14.21 USD |
-3.41
|
$18.18T 21.48B USD | $287 0.34 USD | $11,900 14.07 USD | $12,625 14.92 USD | $18.18T 21.48B USD | 0.99 | $12.06K 14.25 USD | |
| Bayer Aktiengesellschaft BAYA.F | $4.78 5.23 USD |
-0.42
|
$19.4B 21.21B USD | $1K 1.09K USD | $4.78 5.23 USD | $4.78 5.23 USD | $19.4B 21.21B USD | 0 | -$0.65 -0.7 USD | |
| Biogen Inc. BIIB34.SA | $117.12 23.74 USD |
0
|
$103.27B 20.93B USD | $0 0 USD | $0 0 USD | $0 0 USD | $103.27B 20.93B USD | 10.79 | $10.85 2.2 USD | |
| Biogen Inc. IDP.DE | $108.35 118.44 USD |
-0.69
|
$15.86B 17.34B USD | $271 296.24 USD | $108.35 118.44 USD | $111.85 122.27 USD | $15.86B 17.34B USD | 10.64 | $10.18 11.13 USD | |
| Biogen Inc. BIIB.VI | $108.15 118.22 USD |
-0.23
|
$15.85B 17.32B USD | $418 456.93 USD | $108.15 118.22 USD | $112.25 122.7 USD | $15.85B 17.32B USD | 10.59 | $10.21 11.16 USD | |
| Biogen Inc. IDP.F | $103.05 112.65 USD |
-3.69
|
$15.3B 16.72B USD | $100 109.31 USD | $103.05 112.65 USD | $109.15 119.32 USD | $15.3B 16.72B USD | 10.12 | $10.18 11.13 USD | |
| Astellas Pharma Inc. YPHA.F | $7.9 8.64 USD |
+2.6
|
$14.97B 16.36B USD | $0 0 USD | $7.9 8.64 USD | $7.9 8.64 USD | $14.97B 16.36B USD | 0 | -$0.2 -0.2 USD | |
| Astellas Pharma ALPMF | $9 — |
-4.76
|
$16.11B — | $108 — | $9 — | $9 — | $16.11B — | 0 | -$0.22 — | |
| Astellas Pharma Inc. YPH.F | $7.83 8.56 USD |
-3.14
|
$14.13B 15.45B USD | $27 29.51 USD | $7.83 8.56 USD | $8.09 8.84 USD | $14.13B 15.45B USD | 0 | -$0.2 -0.2 USD | |
| Cipla Limited CIPLA.BO | $1,433.45 17.34 USD |
+3.54
|
$1.16T 14.01B USD | $25.2K 304.93 USD | $1,383 16.73 USD | $1,437.1 17.39 USD | $1.16T 14.01B USD | 23.21 | $61.74 0.75 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $47.54 51.97 USD |
+1.93
|
$10.63B 11.63B USD | $0 0 USD | $46.76 51.11 USD | $47.54 51.97 USD | $10.63B 11.63B USD | 23.88 | $1.99 2.18 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $47.5 51.92 USD |
+1.84
|
$10.63B 11.62B USD | $5 5.47 USD | $46.66 51.01 USD | $47.5 51.92 USD | $10.63B 11.62B USD | 23.86 | $1.99 2.18 USD | |
| Orion Oyj OFK0.F | $25.2 27.55 USD |
+1.61
|
$7.21B 7.88B USD | $0 0 USD | $25.2 27.55 USD | $25.2 27.55 USD | $7.21B 7.88B USD | 21.35 | $1.18 1.29 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $2.08 2.27 USD |
+12.43
|
$7.14B 7.81B USD | $250 273.28 USD | $2.08 2.27 USD | $2.08 2.27 USD | $7.14B 7.81B USD | 11.55 | $0.18 0.2 USD | |
| Orion Oyj ORINY | $28.39 — |
0
|
$7.79B — | $248 — | $31.06 — | $31.06 — | $7.79B — | 22.00 | $1.29 — | |
| Kyowa Kirin KYKOF | $14.75 — |
0
|
$7.72B — | $316 — | $14.75 — | $14.75 — | $7.72B — | 19.15 | $0.77 — | |
| CSPC Pharmaceutical CHJTF | $0.6199 — |
+0.1
|
$7.7B — | $20K — | $0.6199 — | $0.6199 — | $7.7B — | 12.40 | $0.05 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $13 14.21 USD |
+3.17
|
$7.01B 7.66B USD | $254 277.66 USD | $12.7 13.88 USD | $13 14.21 USD | $7.01B 7.66B USD | 18.30 | $0.71 0.78 USD | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Abbott India Limited ABBOTINDIA.BO | $29,413.45 355.85 USD |
+1.68
|
$625.02B 7.56B USD | $193 2.33 USD | $29,000 350.85 USD | $29,498.75 356.89 USD | $625.02B 7.56B USD | 46.85 | $627.74 7.59 USD | |
| Abbott India Limited ABBOTINDIA.NS | $29,398.95 355.68 USD |
+1.5
|
$624.71B 7.56B USD | $6.46K 78.16 USD | $28,900.1 349.64 USD | $29,554.85 357.56 USD | $624.71B 7.56B USD | 46.77 | $628.56 7.6 USD | |
| Orion Oyj OFK.F | $48.54 53.06 USD |
-3.5
|
$6.84B 7.48B USD | $66 72.15 USD | $48.54 53.06 USD | $51.15 55.91 USD | $6.84B 7.48B USD | 20.65 | $2.35 2.57 USD | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.56 0.61 USD |
+3.96
|
$6.6B 7.22B USD | $1K 1.09K USD | $0.56 0.61 USD | $0.56 0.61 USD | $6.6B 7.22B USD | 11.13 | $0.05 0.05 USD | |
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
||||||||||
- {{ link.label }} {{link}}